These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10384969)

  • 1. Using flavoxate as primary medication for patients suffering from urge symptomatology.
    Fehrmann-Zumpe P; Karbe K; Blessman G
    Int Urogynecol J Pelvic Floor Dysfunct; 1999; 10(2):91-5. PubMed ID: 10384969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of urgency and urge incontinence with flavoxate in the People's Republic of China.
    Gu FL; Reng ZY; Shang GZ; Shao HX; Wang B; Cheng ZD; Jiang Y; Zhao WP; Zheng JF; Qu CT
    J Int Med Res; 1987; 15(5):312-8. PubMed ID: 3315777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motor urge incontinence: diagnosis and treatment.
    Gaudenz R; Weil A
    Urol Int; 1980; 35(1):1-12. PubMed ID: 7361347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative studies of the effect of mictonorm (propiverin hydrochloride) and Spasuret (flavoxate hydrochloride) on the bladder detrusor muscle].
    Wehnert J; Sage S
    Z Urol Nephrol; 1989 May; 82(5):259-63. PubMed ID: 2665385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of motor urge incontinence with clenbuterol and flavoxate hydrochloride.
    Grüneberger A
    Br J Obstet Gynaecol; 1984 Mar; 91(3):275-8. PubMed ID: 6367811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of flavoxate hydrochloride in the treatment of urge incontinence.
    Ruffmann R
    J Int Med Res; 1988; 16(5):317-30. PubMed ID: 2461883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of the symptoms of urinary urge and urge incontinence with propiverin hydrochloride (Mictonorm)].
    Blau U; Retzke U
    Zentralbl Gynakol; 1984; 106(14):981-7. PubMed ID: 6506904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary urge incontinence: randomised crossover trials of penthienate versus placebo and propantheline.
    Coombes GM; Millard RJ
    Med J Aust; 1996 Nov; 165(9):473-6. PubMed ID: 8937366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flavoxate in urogynecology: an old drug revisited.
    Zor M; Aydur E; Dmochowski RR
    Int Urogynecol J; 2015 Jul; 26(7):959-66. PubMed ID: 25480503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [First experience with flavoxat in bladder - conditioned types of incontinence in gynaecology (author's transl)].
    Briel RC; Gassner K
    Geburtshilfe Frauenheilkd; 1980 Mar; 40(3):242-5. PubMed ID: 6988285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A placebo-controlled, multicentre study comparing the tolerability and efficacy of propiverine and oxybutynin in patients with urgency and urge incontinence.
    Madersbacher H; Halaska M; Voigt R; Alloussi S; Höfner K
    BJU Int; 1999 Oct; 84(6):646-51. PubMed ID: 10510109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug therapy of urinary incontinence in women].
    Gaudenz R
    Med Monatsschr Pharm; 1993 Oct; 16(10):309-11. PubMed ID: 8232059
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical and urodynamic effects of propiverine in patients suffering from urgency and urge incontinence. A multicentre dose-optimizing study.
    Mazur D; Wehnert J; Dorschner W; Schubert G; Herfurth G; Alken RG
    Scand J Urol Nephrol; 1995 Sep; 29(3):289-94. PubMed ID: 8578271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urodynamic changes associated with behavioral and drug treatment of urge incontinence in older women.
    Goode PS; Burgio KL; Locher JL; Umlauf MG; Lloyd LK; Roth DL
    J Am Geriatr Soc; 2002 May; 50(5):808-16. PubMed ID: 12028165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flavoxate in the symptomatic treatment of overactive bladder: a meta-analysis.
    Sweeney P; Mutambirwa S; Van An N; Sharma JB; Vanamail P
    Eur Rev Med Pharmacol Sci; 2016 Sep; 20(17):3703-12. PubMed ID: 27649675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical effects of terodiline hydrochloride on urinary frequency and sense of residual urine--a double blind clinical trial using flavoxate hydrochloride as a control].
    Ogawa A; Shimazaki J; Mitsuya H; Miyazaki S; Kurita T
    Hinyokika Kiyo; 1988 Apr; 34(4):739-53. PubMed ID: 3041785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placebo--the drug of choice in female motor urge incontinence?
    Meyhoff HH; Gerstenberg TC; Nordling J
    Br J Urol; 1983 Feb; 55(1):34-7. PubMed ID: 6337667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The elderly patient with urge incontinence or urge-stress incontinence - efficacy and cardiac safety of propiverine].
    Dorschner W; Stolzenburg JU; Griebenow R; Halaska M; Brünjes R; Frank M; Wieners F
    Aktuelle Urol; 2003 Mar; 34(2):102-8. PubMed ID: 14566693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flavoxate: present and future.
    Arcaniolo D; Conquy S; Tarcan T
    Eur Rev Med Pharmacol Sci; 2015; 19(5):719-31. PubMed ID: 25807422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of flavoxate on uninhibited detrusor contractions and urinary incontinence in the elderly.
    Briggs RS; Castleden CM; Asher MJ
    J Urol; 1980 May; 123(5):665-6. PubMed ID: 7420551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.